Company Name: Benitec Biopharma Ltd.  

Benitec Biopharma Ltd. is a clinical-stage biotechnology company. The company is engaged in the development of treatments for a variety of conditions using its proprietary ddRNAi gene-silencing technology. The company’s current clinical pipeline includes candidates designed to treat:

  • Hepatitis B
  • Hepatitis C
  • Lung Cancer
  • Oculopharyngeal muscular dystrophy
  • Wet Age-related Macular Degeneration

Ticker Symbol: BNTC (NASDAQ)

Ticker Symbol: BLT (Australian Securities Exchange)

Company Website: www.benitec.com

Social Media:

Benitec Biopharma LinkedIn

Benitec Biopharma Twitter

Benitec Biopharma YouTube

Headquarters: Sydney, Australia